|
Graves Disease
|
0.010 |
Biomarker
|
disease |
BEFREE |
This case demonstrates the importance of ECG and cTnI screening among GD patients.
|
30503299 |
2020 |
|
Ventricular arrhythmia
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
The high dose prolonged the repolarization period, induced hemorrhagic tendency, and increased plasma cardiac troponin I level in addition to enhancement of the changes observed after the low dose, whereas it neither affected the cardiac conduction nor induced ventricular arrhythmias.
|
31280457 |
2020 |
|
Arteriosclerosis
|
0.010 |
Biomarker
|
disease |
BEFREE |
We identified patients in the Atherosclerosis Risk in Communities Surveillance Study admitted with chest pain and an initially elevated cardiac troponin I, who presented within 12 hours of symptom onset and were classified with non-ST-segment elevation myocardial infarction.
|
30958029 |
2019 |
|
Atherosclerosis
|
0.010 |
Biomarker
|
disease |
BEFREE |
We identified patients in the Atherosclerosis Risk in Communities Surveillance Study admitted with chest pain and an initially elevated cardiac troponin I, who presented within 12 hours of symptom onset and were classified with non-ST-segment elevation myocardial infarction.
|
30958029 |
2019 |
|
Craniosynostosis
|
0.010 |
Biomarker
|
disease |
BEFREE |
Herein, we introduce a novel surface-enhanced Raman scattering (SERS)-based sandwich immunoassay platform to simultaneously detect cardiac troponin I (cTnI), N-terminal prohormone of brain natriuretic peptide (NT-ProBNP), and neutrophil gelatinase-associated lipocalin (NGAL) for the early diagnosis of CRS by using Raman reporter-molecule-labeled Ag-Au nanostars (Ag-Au NSs) as nanotags and a three-dimensional ordered macroporous (3DOM) Au-Ag-Au plasmonic array as substrate.
|
30499654 |
2019 |
|
Influenza
|
0.010 |
Biomarker
|
disease |
BEFREE |
We applied this method to detect the influenza nucleoprotein (NP) and cardiac troponin I (cTnI).
|
31269392 |
2019 |
|
Muscle Rigidity
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
In the presence of cardiac troponin I (cTnI), the aptamer resides from the electrode surface owing to its rigidity, resulting in a reduction in charge transfer resistance of the modified working electrode and a ratio enhancement of two ECL signals of nGO@TiO<sub>2</sub> NLPs.
|
31480838 |
2019 |
|
Pericardial effusion
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
TNNI3 expression in blood, and MMP9 expression in pericardial fluid, were significantly higher when the cause of death was mechanical asphyxia, probably because of the more sensitive response of these proteins to acute systemic hypoxia/ischemia.
|
31419595 |
2019 |
|
Pneumonia
|
0.010 |
Biomarker
|
disease |
BEFREE |
A small-molecule compound, Robert Costa Memorial drug-1 (RCM-1), has been recently identified from high-throughput screen as an inhibitor of FOXM1 <i>in vitro</i> and in mouse model of allergen-mediated lung inflammation.
|
31040162 |
2019 |
|
Systemic Inflammatory Response Syndrome
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
RESULTS The plasma BNP and cTnI levels in pediatric patients with sepsis were significantly higher than those in the SIRS group (p<0.05).
|
30956276 |
2019 |
|
Cholestasis of pregnancy
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Objective The objective of our study was to determine if a correlation exists between maternal total bile acid levels, degree of maternal pruritus, and fetal cardiac troponin-I levels in asymptomatic patients without a diagnosis of intrahepatic cholestasis of pregnancy.
|
31667041 |
2019 |
|
Left ventricular outflow tract obstruction
|
0.010 |
Biomarker
|
disease |
BEFREE |
We sought to explore the associations between the presence of AF and circulating biomarkers reflecting cardiovascular function (N-terminal pro-brain natriuretic peptide, NT-pro BNP), endothelial function (big endothelin-1, big ET-1), inflammation (high-sensitivity C-reactive protein), and myocardial damage (cardiac troponin I, cTnI) in HCM patients with and without left ventricular outflow tract obstruction (LVOTO).In all, 375 consecutive HCM in-hospital patients were divided into an AF group (n = 90) and a sinus rhythm (SR) group (n = 285) according to their medical history and electrocardiogram results.In comparison with the SR group, peripheral concentrations of big ET-1, NT-pro BNP, and cTnI were significantly higher in patients with AF.
|
30626765 |
2019 |
|
Pregnancy associated hypertension
|
0.010 |
GeneticVariation
|
phenotype |
BEFREE |
In multivariate analysis, PIH (OR: 18.71, P = 0.003), placental abnormality (OR: 26.78, P = 0.007), and decreased hemoglobin after delivery (OR: 2.59, P <0.001) were the factors associated with elevated cTnI.
|
30730993 |
2019 |
|
Non ST segment elevation myocardial infarction
|
0.010 |
Biomarker
|
disease |
BEFREE |
We identified patients in the Atherosclerosis Risk in Communities Surveillance Study admitted with chest pain and an initially elevated cardiac troponin I, who presented within 12 hours of symptom onset and were classified with non-ST-segment elevation myocardial infarction.
|
30958029 |
2019 |
|
Chronic Kidney Diseases
|
0.010 |
Biomarker
|
group |
BEFREE |
Commonly, cardiac troponin T (CTnT), cardiac troponin I (CTnI) or creatine kinase muscle/brain subtype (CK-MB) have been used as cardiac biomarkers to assess ACS with certain limitations, such as increased time to rise for diagnosis and increased levels in the patients with chronic kidney disease (CKD).
|
31772848 |
2019 |
|
Autoimmune myocarditis
|
0.010 |
Biomarker
|
disease |
BEFREE |
Animals immunized with cTnI developed autoimmune myocarditis with a significant deterioration of cardiac parameters compared to the corresponding control group.
|
30716658 |
2019 |
|
Severe Sepsis
|
0.010 |
Biomarker
|
disease |
BEFREE |
In this study, none of LVSD, cTnI, and NT-proBNP was associated with the prognosis of pediatric severe sepsis.
|
30921240 |
2019 |
|
Takotsubo Cardiomyopathy
|
0.010 |
Biomarker
|
disease |
BEFREE |
Our aim was to investigate whether strain values by STE and cardiac troponin I (cTnI) could predict early myocardial injury in rats with SCM.
|
31765453 |
2019 |
|
Idiopathic pulmonary arterial hypertension
|
0.010 |
Biomarker
|
disease |
BEFREE |
Brain natriuretic peptide (BNP) and cardiac troponin I (cTnI) were measured simultaneously in 151 consecutive patients with no history of heart disease or pulmonary arterial hypertension (PAH).
|
30068764 |
2019 |
|
Multiple Chronic Conditions
|
0.010 |
Biomarker
|
disease |
BEFREE |
Advancements in health care monitoring demand a rapid, accurate and reliable early diagnosis of "Heart Attack" (acute myocardial infarction) with an objective to develop a cost-effective, rapid and label-free point of care diagnostic test kit for the detection of cardiac troponin I (cTnI) on paper-based multi-frequency impedimetric transducers.
|
31844990 |
2019 |
|
Alopecia
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Alopecia areata plasma samples with high cardiac troponin I levels also induced significantly higher rates of cardiomyocyte apoptosis in cell culture assays.
|
29740659 |
2018 |
|
Alopecia Areata
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Alopecia areata plasma samples with high cardiac troponin I levels also induced significantly higher rates of cardiomyocyte apoptosis in cell culture assays.
|
29740659 |
2018 |
|
Rheumatoid Arthritis
|
0.010 |
Biomarker
|
disease |
BEFREE |
High-sensitivity cardiac troponin I is a biomarker for occult coronary plaque burden and cardiovascular events in patients with rheumatoid arthritis.
|
29554376 |
2018 |
|
Hamartoma Syndrome, Multiple
|
0.010 |
Biomarker
|
disease |
BEFREE |
Furthermore, in the Cox proportional hazard analysis, cTnI, but not ACE, IL2R or BNP, was a predictor of fatal arrhythmia in sarcoidosis patients (HR 2.418, P = 0.003).Higher ACE and sIL2-R are associated with systemic lesions, whereas BNP is a useful marker for detecting cardiac involvement in sarcoidosis patients. cTnI is a predictor of fatal arrhythmia in CS patients.
|
30101857 |
2018 |
|
Chronic Obstructive Airway Disease
|
0.010 |
Biomarker
|
disease |
BEFREE |
This study evaluated the association between high-sensitivity cardiac troponin I concentration and cardiovascular events in patients with COPD and heightened cardiovascular risk.
|
30165984 |
2018 |